Dyslipidemia Collection
 21-40 of 49 Articles
ACP Journal Club |  20 November 2012
Review: Lipid-lowering drugs decrease all-cause and cardiac mortality and CV events in CKD
G. V. Ramesh Prasad, MBBS, FRCPC
Ann Intern Med. 2012;157(10):JC5-5. doi:10.7326/0003-4819-157-10-201211200-02005
ACP Journal Club |  16 October 2012
Meta-analysis: Lowering LDL-C levels using statins reduces major vascular events regardless of baseline risk
Meera Jain, MD; Mark Rosenberg, MD
Ann Intern Med. 2012;157(8):JC4-2. doi:10.7326/0003-4819-157-8-201210160-02002
ACP Journal Club |  16 October 2012
Review: Quality improvement strategies reduce HbA1c, LDL cholesterol, and BP in diabetes
Sean F. Dinneen, MD; Máire O’Donnell, PhD
Ann Intern Med. 2012;157(8):JC4-11. doi:10.7326/0003-4819-157-8-201210160-02011
ACP Journal Club |  18 September 2012
Daily n-3 fatty acid supplements did not reduce CV events in high-risk patients with dysglycemia
Ellis Lader, MD
Ann Intern Med. 2012;157(6):JC3-11. doi:10.7326/0003-4819-157-6-201209180-02011
ACP Journal Club |  20 March 2012
Simvastatin reduced major vascular events at 5 years in at-risk patients; benefits were maintained at 11 years
Edward P. Havranek, MD
Ann Intern Med. 2012;156(6):JC3-5. doi:10.7326/0003-4819-156-6-201202210-02005
ACP Journal Club |  20 March 2012
Review: Statins do not increase risk for intracerebral hemorrhage
David C. Anderson, MD
Ann Intern Med. 2012;156(6):JC3-6. doi:10.7326/0003-4819-156-6-201202210-02006
ACP Journal Club |  17 January 2012
Review: Interventions to reduce or modify dietary fat reduce cardiovascular events
Scott Kahan, MD, MPH; Yoni Freedhoff, MD
Ann Intern Med. 2012;156(2):JC1-5. doi:10.7326/0003-4819-156-2-201201170-02005
ACP Journal Club |  20 December 2011
Review: Insufficient evidence exists to determine the benefits and risks of statins for acute ischemic stroke or TIA
Robert L. Trowbridge, MD
Ann Intern Med. 2011;155(12):JC6-6. doi:10.7326/0003-4819-155-12-201112200-02006
ACP Journal Club |  15 November 2011
Simvastatin plus ezetimibe reduced major atherosclerotic events in patients with chronic kidney disease
Maurice Laville, MD
Ann Intern Med. 2011;155(10):JC5-2. doi:10.7326/0003-4819-155-10-201111150-02002
ACP Journal Club |  18 October 2011
Review: Intensive-dose statin therapy increases incident diabetes compared with moderate-dose therapy
Elizabeth Barrett-Connor, MD
Ann Intern Med. 2011;155(8):JC4-7. doi:10.7326/0003-4819-155-8-201110180-02007
ACP Journal Club |  16 August 2011
Meta-analysis: High-dose statin pretreatment prevents periprocedural cardiac events in patients having PCI
Emil L. Fosbol, MD, PhD; Christopher B. Granger, MD
Ann Intern Med. 2011;155(4):JC2-8. doi:10.7326/0003-4819-155-4-201108160-02008
ACP Journal Club |  17 May 2011
Meta-analysis: More intensive statin therapy prevents major vascular events
Donald A. Smith, MD, MPH, FACP, FNLA, FACE
Ann Intern Med. 2011;154(10):JC5-3. doi:10.7326/0003-4819-154-10-201105170-02003
ACP Journal Club |  17 May 2011
Prescription omega-3 fatty acids did not prevent recurrent, symptomatic, paroxysmal or persistent atrial fibrillation
Brian Olshansky, MD
Ann Intern Med. 2011;154(10):JC5-9. doi:10.7326/0003-4819-154-10-201105170-02009
ACP Journal Club |  16 November 2010
Intensifying glucose control and adding fenofibrate to simvastatin each reduced progression of retinopathy in type 2 diabetes
David L. Bronson, MD, FACP
Ann Intern Med. 2010;153(10):JC5-10. doi:10.7326/0003-4819-153-10-201011160-02010
ACP Journal Club |  21 September 2010
Review: Statins do not reduce mortality in patients with no history of cardiovascular disease
David J. Maron, MD
Ann Intern Med. 2010;153(6):JC3-4. doi:10.7326/0003-4819-153-6-201009210-02004
ACP Journal Club |  20 July 2010
Fenofibrate plus simvastatin did not prevent major CV events more than simvastatin alone in type 2 diabetes
C. Raina Elley, MBChB, PhD; Vanessa Selak, MBChB, MPH
Ann Intern Med. 2010;153(2):JC1-5. doi:10.7326/0003-4819-153-2-201007200-02005
ACP Journal Club |  15 June 2010
Rosuvastatin prevented ischemic stroke in healthy older adults with elevated C-reactive protein
Salvador Cruz-Flores, MD, MPH
Ann Intern Med. 2010;152(12):JC6-6. doi:10.7326/0003-4819-152-12-201006150-02006
ACP Journal Club |  15 June 2010
Review: Statin use increases risk for diabetes
John-Michael Gamble, BScPharm, MSc; Sumit R. Majumdar, MD, MPH
Ann Intern Med. 2010;152(12):JC6-7. doi:10.7326/0003-4819-152-12-201006150-02007
ACP Journal Club |  20 April 2010
Review: Statins do not reduce mortality in patients with heart failure
Christopher B. Granger, MD; Chetan B. Patel, MD
Ann Intern Med. 2010;152(8):JC4-6. doi:10.7326/0003-4819-152-8-201004200-02006
ACP Journal Club |  16 February 2010
Either cholesterol or apolipoprotein levels can be used to determine risk for CVD; triglycerides are not useful
Matthew J. McQueen, MD, PhD; Allan Sniderman, MD
Ann Intern Med. 2010;152(4):JC2-12. doi:10.7326/0003-4819-152-4-201002160-02012
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.